These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27170663)

  • 1. Pravastatin Effects on Placental Prosurvival Molecular Pathways in a Mouse Model of Preeclampsia.
    Saad AF; Diken ZM; Kechichian TB; Clark SM; Olson GL; Saade GR; Costantine MM
    Reprod Sci; 2016 Nov; 23(11):1593-1599. PubMed ID: 27170663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model.
    McDonnold M; Tamayo E; Kechichian T; Gamble P; Longo M; Hankins GD; Saade GR; Costantine MM
    Am J Obstet Gynecol; 2014 Jun; 210(6):542.e1-7. PubMed ID: 24412113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia.
    Costantine MM; Tamayo E; Lu F; Bytautiene E; Longo M; Hankins GDV; Saade GR
    Obstet Gynecol; 2010 Jul; 116(1):114-120. PubMed ID: 20567176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia.
    Fox KA; Longo M; Tamayo E; Kechichian T; Bytautiene E; Hankins GD; Saade GR; Costantine MM
    Am J Obstet Gynecol; 2011 Oct; 205(4):366.e1-5. PubMed ID: 22083058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model.
    Carver AR; Andrikopoulou M; Lei J; Tamayo E; Gamble P; Hou Z; Zhang J; Mori S; Saade GR; Costantine MM; Burd I
    PLoS One; 2014; 9(6):e100873. PubMed ID: 24963809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice.
    Lu F; Longo M; Tamayo E; Maner W; Al-Hendy A; Anderson GD; Hankins GD; Saade GR
    Am J Obstet Gynecol; 2007 Apr; 196(4):396.e1-7; discussion 396.e7. PubMed ID: 17403433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
    Luo X; Liu DD; Qi HB; Yao ZW
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin alleviates oxidative stress and decreases placental trophoblastic cell apoptosis through IL-6/STAT3 signaling pathway in preeclampsia rats.
    Wang GJ; Yang Z; Huai J; Xiang QQ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12955-12962. PubMed ID: 33378046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia.
    Tan L; Kluivers ACM; Cruz-López EO; Broekhuizen M; Chen Z; Neuman RI; Schoenmakers S; Ruijgrok L; van de Velde D; de Winter BCM; van den Bogaerdt AJ; Lu X; Danser AHJ; Verdonk K
    Hypertension; 2024 Apr; 81(4):861-875. PubMed ID: 38361240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion.
    Hastie R; Brownfoot FC; Pritchard N; Hannan NJ; Cannon P; Nguyen V; Palmer K; Beard S; Tong S; Kaitu'u-Lino TJ
    Hypertension; 2019 Mar; 73(3):659-670. PubMed ID: 30636550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
    Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
    DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.